Published in
American Academy of Pediatrics, Pediatrics, Supplement_4(142), p. S242-S242, 2018
DOI: 10.1542/peds.2018-2420ccc
Elsevier, Journal of Allergy and Clinical Immunology: In Practice, 2(6), p. 476-485.e3
DOI: 10.1016/j.jaip.2017.09.016
Links
Tools
Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial
Journal article published in 2018 by
J. Andrew Bird,
Jonathan M. Spergel 
,
Stacie M. Jones,
Rima Rachid,
Amal H. Assa'ad,
Julie Wang,
Veena Agusala,
Stephanie A. Leonard,
Susan S. Laubach,
Edwin H. Kim,
Brian P. Vickery,
Brooke I. Polk,
Benjamin P. Davis,
Jennifer Heimall,
Antonella Cianferoni
and other authors.
,
Stacie M. Jones,
Rima Rachid,
Amal H. Assa'ad,
Julie Wang,
Veena Agusala,
Stephanie A. Leonard,
Susan S. Laubach,
Edwin H. Kim,
Brian P. Vickery,
Brooke I. Polk,
Benjamin P. Davis,
Jennifer Heimall,
Antonella Cianferoni
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 